New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 14, 2014
18:15 EDTTSO, APOL, MPC, VLO, SAVE, HFC, NURO, PPHMOn The Fly: After Hours Movers
UP AFTER EARNINGS: Peregrine Pharmaceuticals (PPHM), up 2.3% after reports fourth quarter results. ALSO HIGHER: Spirit Airlines (SAVE), up 1.5% after Lone Pine Capital reported a 6% passive stake. LOWER: Apollo Education (APOL), down 6.2% following an announcement that the Department of Education intends to conduct an ordinary course program review of University of Phoenix... Neurometrix (NURO), down just under 1% after the company files to sell 5.89M shares of common stock for holders. NOTABLE: Valero Energy (VLO), down 3.4% after announcing second quarter guidance below analyst estimates... Tesoro (TSO), down almost 1%, HollyFrontier (HFC), down marginally, and Marathon Petroleum (MPC), down fractionally, are also lower following Valero Energy's announcement.
News For PPHM;SAVE;APOL;NURO;VLO;TSO;HFC;MPC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 3, 2015
08:04 EDTHFCHollyFrontier, Holly Energy agree in principle El Dorado unit acquisition
HollyFrontier Corporation (HFC) and Holly Energy Partners, L.P. (HEP) announced an agreement in principle for the acquisition by Holly Energy of the newly constructed naphtha fractionation and hydrogen generation units at HollyFrontier's El Dorado refinery. Holly Energy is expected to pay HollyFrontier cash consideration of approximately $62M, subject to the execution of definitive agreements and other customary closing conditions. Both HollyFrontier and Holly Energy expect the proposed transaction will close during the fourth quarter of 2015. In connection with the closing of the proposed transaction, HollyFrontier and Holly Energy expect to enter into 15-year tolling agreements containing minimum quarterly throughput commitments from HollyFrontier. Holly Energy expects that the transaction will be immediately accretive to unitholders.
September 2, 2015
10:04 EDTSAVEHigh option volume stocks: AGI TSM SAVE DXJ LAD
September 1, 2015
11:38 EDTHFCHollyFrontier and Holly Energy Partners hold a joint analyst day
Joint Analyst Day is being held in Dallas, Texas on September 3 at 9 am. Webcast Link
August 31, 2015
10:31 EDTNURONeuroMetrix reports pilot study data of wearable pain relief technology
NeuroMetrix announced preliminary results from a pilot study of its wearable pain relief technology in subjects with restless leg syndrome. RLS, which is also known as Willis-Ekbom Disease, is a common sleep disorder characterized by a strong urge to move the legs at night. The pilot study was an open-label, single-arm, flexible dosing, 4-week trial. The objective of the study was to determine if transcutaneous electrical nerve stimulation, when delivered using a wearable intensive nerve stimulation device, is an effective and safe treatment for RLS, and to explore its effect on sleep in subjects with RLS. A total of nine subjects were evaluated. Two-thirds of the subjects were responders to the therapy according to the Clinical Global Impression of improvement scale. Overall RLS severity decreased by 32%, as assessed by the International Restless Leg Syndrome scale, which was statistically significant. Similarly, several sleep related outcomes measures showed statistically significant improvement. A complete set of results and analyses will be published by Dr. Winkelman who stated, "Pharmacologic treatments, though an important advance over the past 20 years for patients with RLS, leave much to be desired. Effective non-pharmacological treatments would be of great value, and these are encouraging preliminary results that must now be confirmed in a sham-controlled study."
09:39 EDTSAVEBoyd Group International to hold a summit
Subscribe for More Information
August 27, 2015
07:15 EDTNURONeuroMetrix reports over 200,000 members assessed with DPNCheck
Subscribe for More Information
August 26, 2015
10:00 EDTMPCOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:04 EDTPPHMPeregrine presents bavituximab data showing estimated survival curves at plateau
Subscribe for More Information
07:05 EDTMPCMarathon Petroleum upgraded to Overweight from Neutral at JPMorgan
JPMorgan upgraded Marathon Petroleum to Overweight with a $61 price target. The firm believes Marathon's valuation is too attractive to ignore and the weaker Q2 capture rate was transitory and risks are reflected in shares.
August 24, 2015
09:45 EDTVLO, MPCOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:18 EDTPPHMOn The Fly: Pre-market Movers
Subscribe for More Information
07:24 EDTHFCHollyFrontier downgraded to Underperform from Neutral at BofA/Merrill
Subscribe for More Information
07:24 EDTVLOValero downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merill downgraded Valero to Underperform and raised its price target to $68 from $64. The firm believes the Refining sector has reverted to a trading sector and downgrade shares ahead of a seasonal slow-down in demand and a deteriorating macro backdrop.
07:24 EDTMPCMarathon Petroleum downgraded to Underperform from Neutral at BofA/Merrill
Subscribe for More Information
05:13 EDTPPHMAstraZeneca to collaborate with Peregrine on cancer immunotherapy clinical trial
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use